Evaluation of the concordance of ER, PR, HER2, and Ki-67 expression levels between primary breast tumors and their liver metastases: a retrospective analysis of 57 cases
- 1 October 2025
- journal article
- Published by Pamukkale University in Pamukkale Medical Journal
- No. Advanced O,p. 5
Abstract
Purpose: This study aims to evaluate the changes in estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67 expression between primary breast tumors and their liver metastases. Materials and methods: A total of 57 patients with breast cancer liver metastases were included. Immunohistochemical staining was performed to assess ER, PR, HER2, and Ki-67 expression in both primary and metastatic tumors. HER2 status was confirmed by silver in situ hybridization (SISH) when necessary. Statistical analyses were conducted to evaluate changes in biomarker expression. Results: Comparison of biomarker expression between primary and metastatic biopsies revealed changes in ER status in 5 cases (1 from negative to positive, 4 from positive to negative); PR status in 22 cases (4 from negative to positive, 18 from positive to negative); HER2 status in 5 cases (2 from negative to positive, 3 from positive to negative); and Ki-67 status in 13 cases (6 from low to high, 7 from high to low). The discordance rates for ER, PR, HER2, and Ki-67 were calculated as 8.8%, 38.6%, 8.8%, and 28.9%, respectively. Conclusion: Our findings confirm that biomarker expression may change between primary and metastatic breast cancer lesions. Given the crucial role of receptor status in treatment decisions, re-biopsy of metastatic lesions is essential to guide personalized therapy.Keywords
This publication has 18 references indexed in Scilit:
- Study of Biomarker Discordance between Primary and Recurrent Sites and its Clinical Implications in Metastatic Breast Cancer : A Single Institutional Study from IndiaSouth Asian Journal of Cancer, 2023
- Incidence and prognostic significance of receptor discordance between primary breast cancer and paired bone metastasesInternational Journal of Cancer, 2022
- Receptor conversion in metastatic breast cancer: analysis of 390 cases from a single institutionLaboratory Investigation, 2020
- 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)Annals of Oncology, 2018
- Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)European Journal of Cancer, 2017
- A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastasesEuropean Journal of Cancer, 2014
- Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registryBreast Cancer Research and Treatment, 2013
- Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patientsBritish Journal of Cancer, 2007
- Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: Clinical implicationsMolecular Oncology, 2007
- Estrogen receptor protein (ERP) in multiple tumor specimens from individual patients with breast cancerCancer, 1977